Home › Trial NCT03223597
Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223
- Trial IDNCT03223597
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorThe Netherlands Cancer Institute
- Enrollment300
- Start date2015-01-17
- ConditionsProstate Cancer Metastatic · Bone Metastases
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.